ZMB Member Ralf Küppers
ZMB Member
Ralf Küppers
Next ZMB-Member
Prof. Dr. Ralf Küppers
Director of:
Institute of Cell Biology (Tumor Research)
University Hospital Essen
Virchowstr. 173
45122 Essen
- +49 201 723 3384
- Website
- Selected Publications
- Publication Metrics
-

- ZMB Research Program
Oncology
Research Overview
B lymphocytes represent the white blood cells that produce antibodies and that play an important role in immune responses against foreign antigens (e.g. bacteria). In rare instances, B lymphocytes may undergo malignant transformation and become tumour cells. Such tumours are called B cell lymphomas or leukemias. The main research topics of the group are:
- Investigation of B cell differentiation and function in the human
- The interplay of B cells with viruses (EBV, HCV, HIV)
- Pathogenesis of human B cell lymphomas, in particular Hodgkin lymphoma
Selected Publications
-
Common origin and somatic mutation patterns of composite lymphomas and leukemiasIn: Leukemia, Vol. 39, 2025, Nr. 8, pp. 1960 – 1971DOI (Open Access)
-
Genetic lesions in nodular lymphocyte-predominant Hodgkin lymphoma and T cell/histiocyte-rich large B-cell lymphoma identified by whole genome sequencingIn: Leukemia, Vol. 39, 2025, Nr. 9, pp. 2215 – 2225DOI (Open Access)
-
Subgrouping germinal center-derived B-cell lymphomas based on machine learning-deduced DNA methylation modulesIn: Leukemia, Vol. 39, 2025, Nr. 4, pp. 967 – 971DOI (Open Access)
-
Author Correction : Patterns of somatic structural variation in human cancer genomesIn: Nature, Vol. 614, 2023, Nr. 7948, pp. E38DOI (Open Access)
-
Author Correction : Analyses of non-coding somatic drivers in 2,658 cancer whole genomesIn: Nature, Vol. 614, 2023, pp. E40DOI (Open Access)
-
Author Correction : The evolutionary history of 2,658 cancersIn: Nature, Vol. 614, 2023, E42DOI (Open Access)
-
Author Correction : Genomic basis for RNA alterations in cancerIn: Nature, Vol. 614, 2023, Nr. 7948, pp. E37DOI (Open Access)
-
Author Correction : Butler enables rapid cloud-based analysis of thousands of human genomesIn: Nature Biotechnology, Vol. 41, 2023, Nr. 4, pp. 577DOI (Open Access)
-
Author Correction: : The repertoire of mutational signatures in human cancerIn: Nature, Vol. 614, 2023, pp. E41DOI (Open Access)
-
Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencingIn: Nature Genetics, Vol. 55, 2023, Nr. 6, 1076DOI (Open Access)
-
Author Correction: Disruption of chromatin folding domains by somatic genomic rearrangements in human cancerIn: Nature Genetics, Vol. 55, 2023, Nr. 6, pp. 1079DOI (Open Access)
-
Author Correction: Pan-cancer analysis of whole genomesIn: Nature, Vol. 614, 2023, Nr. 7948, pp. E39DOI (Open Access)
-
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencingIn: Nature Genetics, Vol. 52, 2023, pp. 331 – 341DOI (Open Access)
-
Disruption of chromatin folding domains by somatic genomic rearrangements in human cancerIn: Nature Genetics, Vol. 52, 2023, Nr. 3, pp. 294 – 305DOI (Open Access)
-
The landscape of viral associations in human cancersIn: Nature Genetics, 2023, Nr. 52, pp. 320 – 330DOI (Open Access)
-
The repertoire of mutational signatures in human cancerIn: Nature, Vol. 578, 2023, Nr. 7793, pp. 94 – 101DOI (Open Access)
-
Transcriptional reprogramming by mutated IRF4 in lymphomaIn: Nature Communications, Vol. 14, 2023, Nr. 1, 6947DOI (Open Access)
-
Author Correction : Divergent mutational processes distinguish hypoxic and normoxic tumoursIn: Nature Communications, Vol. 13, 2022, 7569DOI (Open Access)
-
Author Correction : Combined burden and functional impact tests for cancer driver discovery using DriverPowerIn: Nature Communications, Vol. 13, 2022, 7571DOI (Open Access)
-
Author Correction : A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patternsIn: Nature Communications, Vol. 13, 2022, 7573DOI (Open Access)
-
Author Correction : High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterationsIn: Nature Communications, Vol. 13, 2022, 7572DOI (Open Access)
-
Author Correction : Inferring structural variant cancer cell fractionIn: Nature Communications, Vol. 13, 2022, 7568DOI (Open Access)
-
Author Correction : Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSigIn: Nature Communications, Vol. 13, 2022, 7567DOI (Open Access)
-
Author Correction : Genomic footprints of activated telomere maintenance mechanisms in cancerIn: Nature Communications, Vol. 13, 2022, 7574DOI (Open Access)
-
Author Correction : Integrative pathway enrichment analysis of multivariate omics dataIn: Nature Communications, Vol. 13, 2022, 7570DOI (Open Access)
-
Author Correction : Pathway and network analysis of more than 2500 whole cancer genomesIn: Nature Communications, Vol. 13, 2022, 7566DOI (Open Access)
-
The Biology of Ocular Adnexal Marginal Zone LymphomasIn: Cancers, Vol. 14, 2022, Nr. 5, 1264DOI, Online Full Text (Open Access)
-
Impact of a faulty germinal center reaction on the pathogenesis of primary diffuse large b cell lymphoma of the central nervous systemIn: Cancers, Vol. 13, 2021, Nr. 24, 6334DOI (Open Access)
-
Molecular biology of Hodgkin lymphomaIn: Leukemia, Vol. 35, 2021, Nr. 4, pp. 968 – 981DOI (Open Access)
-
Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomasIn: Leukemia, Vol. 35, 2021, pp. 2002 – 2016DOI (Open Access)
-
Sugar-modified B-cell receptors in DLBCLIn: Blood, Vol. 138, 2021, Nr. 17, pp. 1512 – 1514DOI (Open Access)
-
UMI or not UMI, that is the question for scRNA-seq zero-inflationIn: Nature Biotechnology, Vol. 39, 2021, Nr. 2, pp. 158 – 159DOI, Online Full Text (Open Access)
-
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patternsIn: Nature Communications, Vol. 11, 2020, 728DOI (Open Access)
-
Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samplesIn: Nature Communications, Vol. 11, 2020, Nr. 1, pp. 6232DOI (Open Access)
-
Combined burden and functional impact tests for cancer driver discovery using DriverPowerIn: Nature Communications, Vol. 11, 2020, 734DOI (Open Access)
-
Divergent mutational processes distinguish hypoxic and normoxic tumoursIn: Nature Communications, Vol. 11, 2020, 737DOI (Open Access)
-
Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypesIn: Blood, Vol. 136, 2020, Nr. 12, pp. 1419 – 1432DOI, Online Full Text (Open Access)
-
Genomic footprints of activated telomere maintenance mechanisms in cancerIn: Nature Communications, Vol. 11, 2020, 733DOI (Open Access)
-
High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterationsIn: Nature Communications, Vol. 11, 2020, 736DOI (Open Access)
-
Identifying genetic lesions in ocular adnexal extranodal marginal zone lymphomas of the malt subtype by whole genome, whole exome and targeted sequencingIn: Cancers, Vol. 12, 2020, Nr. 4, 986DOI, Online Full Text (Open Access)
-
Inferring structural variant cancer cell fractionIn: Nature Communications, Vol. 11, 2020, 730DOI (Open Access)
-
Integrative pathway enrichment analysis of multivariate omics dataIn: Nature Communications, Vol. 11, 2020, 735DOI (Open Access)
-
Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphomaIn: Nature Communications, Vol. 11, 2020, Nr. 1, pp. 2465DOI (Open Access)
-
Pan-cancer analysis of whole genomesIn: Nature, Vol. 578, 2020, Nr. 7793, pp. 82 – 93DOI (Open Access)
-
Pathway and network analysis of more than 2500 whole cancer genomesIn: Nature Communications, Vol. 11, 2020, 729DOI (Open Access)
-
Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSigIn: Nature Communications, Vol. 11, 2020, 731DOI (Open Access)
-
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samplesIn: Nature Communications, Vol. 11, 2020, Nr. 1, pp. 4748DOI (Open Access)
-
Sex differences in oncogenic mutational processesIn: Nature Communications, Vol. 11, 2020, Nr. 1, pp. 4330DOI (Open Access)
-
Fibroblasts in nodular sclerosing classical Hodgkin lymphoma are defined by a specific phenotype and protect tumor cells from brentuximab-Vedotin induced injuryIn: Cancers, Vol. 11, 2019, Nr. 11, Article-No: 1687DOI (Open Access)
-
Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphomaIn: Nature Communications, Vol. 10, 2019, Nr. 1, pp. 1459DOI (Open Access)
-
MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt LymphomaIn: Cancer Research, Vol. 79, 2019, Nr. 12, pp. 3125 – 3138DOI (Open Access)
-
Migration properties distinguish tumor cells of classical hodgkin lymphoma from anaplastic large cell lymphoma cellsIn: Cancers, Vol. 11, 2019, Nr. 10, pp. 1484DOI (Open Access)
-
An oncogenic axis of STAT-mediated BATF3 upregulation causing MYC activity in classical Hodgkin lymphoma and anaplastic large cell lymphomaIn: Leukemia, Vol. 32, 2018, Nr. 1, pp. 92 – 101
-
Biased IGH VDJ gene repertoire and clonal expansions in B cells of chronically hepatitis C virus–infected individualsIn: Blood, Vol. 131, 2018, Nr. 5, pp. 546 – 557DOI (Open Access)
-
Critical influences on the pathogenesis of follicular lymphomaIn: Blood, Vol. 131, 2018, Nr. 21, pp. 2297 – 2306DOI (Open Access)
-
IG-MYC⁺ neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomasIn: Blood, Vol. 132, 2018, Nr. 21, pp. 2280 – 2285DOI (Open Access)
-
DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemiaIn: Nature Genetics, Vol. 48, 2016, Nr. 3, pp. 253 – 264DOI, Online Full Text (Open Access)
-
Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphomaIn: Blood, Vol. 128, 2016, Nr. 23, pp. 2666 – 2670DOI (Open Access)
-
Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphomaIn: Leukemia, Vol. 30, 2016, Nr. 4, pp. 844 – 853
-
The International Human Epigenome Consortium : A Blueprint for Scientific Collaboration and DiscoveryIn: Cell, Vol. 167, 2016, Nr. 5, pp. 1145 – 1149DOI (Open Access)
-
CEACAM1 induces B-cell survival and is essential for protective antiviral antibody productionIn: Nature Communications, Vol. 6, 2015, 6217DOI (Open Access)
-
DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional controlIn: Nature Genetics, Vol. 47, 2015, Nr. 11, pp. 1316 – 1325DOI, Online Full Text (Open Access)
-
Genomic and epigenomic co-evolution in follicular lymphomasIn: Leukemia, Vol. 29, 2015, Nr. 2, pp. 456 – 463
-
Progressive Epigenetic Programming during B Cell Maturation Is Reflected in a Continuum of Epigenetic Disease Phenotypes in Chronic Lymphocytic LeukemiaIn: Blood, Vol. 126, 2015, Nr. 23, pp. 2436
-
Whole-genome fingerprint of the DNA methylome during human B cell differentiationIn: Nature Genetics, Vol. 47, 2015, Nr. 7, pp. 746 – 756DOI, Online Full Text (Open Access)
-
A microRNA involved in the germinal center reactionIn: Blood, Vol. 124, 2014, Nr. 2, pp. 158 – 159DOI, Online Full Text (Open Access)
-
A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphomaIn: Blood, Vol. 123, 2014, Nr. 8, pp. 1187 – 1198
-
Characterization of the DNA Methylome during Human B-Cell DifferentiationIn: Blood, Vol. 124, 2014, Nr. 21, pp. 4346
-
Pathogenesis, diagnosis, and treatment of composite lymphomasIn: The Lancet Oncology, Vol. 15, 2014, Nr. 10, pp. e435 – 46
-
The PRDX2 gene is transcriptionally silenced and de novo methylated in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphomaIn: Blood, Vol. 123, 2014, Nr. 23, pp. 3672 – 3674
-
Role of early B-cell factor 1 (EBF1) in Hodgkin lymphomaIn: Leukemia, Vol. 27, 2013, Nr. 3, pp. 671 – 679
-
Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphomaIn: Blood, Vol. 120, 2012, Nr. 23, pp. 4609 – 4620
-
Array-based DNA methylation analysis in classical Hodgkin lymphoma reveals new insights into the mechanisms underlying silencing of B cell-specific genesIn: Leukemia, Vol. 26, 2012, Nr. 1, pp. 185 – 188
-
BLUEPRINT to decode the epigenetic signature written in bloodIn: Nature Biotechnology, Vol. 30, 2012, Nr. 3, pp. 224 – 226
-
Combined SNP Microarray Based Genomic Mapping and Next Generation Transcriptome Sequencing Confirms the Presence of Somatic STAT3 Mutations and Identifies Novel Chromosomal Imbalances and Candidate Genes in T Large Granular Lymphocytic Leukemia (T-LGL)In: Blood, Vol. 120, 2012, Nr. 21, pp. 3512
-
Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infectionIn: Leukemia, Vol. 26, 2012, Nr. 7, pp. 1654 – 1662
-
Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencingIn: Nature Genetics, Vol. 44, 2012, Nr. 12, pp. 1316 – 1320
-
Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphomaIn: Leukemia, Vol. 25, 2011, Nr. 12, pp. 1797 – 1807
-
Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adultsIn: Blood, Vol. 118, 2011, Nr. 1, pp. 139 – 147
-
From pathogenesis to treatment of chronic lymphocytic leukaemiaIn: Nature Reviews Cancer, Vol. 10, 2010, Nr. 1, pp. 37 – 50
-
Genomic imbalances in Hodgkin lymphomaIn: Blood, Vol. 116, 2010, Nr. 3, pp. 309 – 311DOI (Open Access)
-
Mechanisms of aberrant GATA3 expression in classical Hodgkin lymphoma and its consequences for the cytokine profile of Hodgkin and Reed/Sternberg cellsIn: Blood, Vol. 116, 2010, Nr. 20, pp. 4202 – 4211DOI (Open Access)
-
Mutations of CARD11 but not TNFAIP3 may activate the NF-κB pathway in primary CNS lymphomaIn: Acta Neuropathologica, Vol. 120, 2010, Nr. 4, pp. 529 – 535
-
The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemiaIn: Leukemia, Vol. 24, 2010, Nr. 6, pp. 1152 – 1159
